GlaxoSmithKline Pharmaceuticals Announcements
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled "Company forays into Oncology lwith Jemperli and Zejula, Bringing...
25 Aug, 2025 | 11:25am • Source: NSE
Cpmpany foarys into Oncology with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers
25 Aug, 2025 | 11:17am • Source: NSE
Company forays into Oncology with Jemperli & Zejula , bringing precisions therapies for Gynaecological Cancers
25 Aug, 2025 | 11:03am • Source: BSE
Company forays into oncology with jemperli & Zejula bringing precision therapies for Gynaecological cancers
25 Aug, 2025 | 11:00am • Source: BSE
As per attachment
08 Aug, 2025 | 10:31am • Source: BSE
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
04 Aug, 2025 | 02:08pm • Source: NSE
As per attachment
04 Aug, 2025 | 11:44am • Source: BSE
Clarification on news item appearing in Moneycontrol.com
04 Aug, 2025 | 11:27am • Source: BSE
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 1, 2025, with reference to news appeared in https://www.moneycontrol.com dated August 1, 2025 quoting...
01 Aug, 2025 | 04:48pm • Source: BSE
As per attachment
01 Aug, 2025 | 03:22pm • Source: BSE
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2025, titled "Media release: Q1 of 2025-26
01 Aug, 2025 | 01:47pm • Source: NSE
GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025
01 Aug, 2025 | 01:37pm • Source: NSE
As per attachment
01 Aug, 2025 | 01:33pm • Source: BSE
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Schedule of meet
28 Jul, 2025 | 11:59am • Source: NSE
As per attachment
28 Jul, 2025 | 11:48am • Source: BSE
As per attachment
23 Jul, 2025 | 03:58pm • Source: BSE